Takeda Makes Last-Gasp Move for Rival Drugmaker Shire

Terms of Japanese firm’s fifth takeover proposal aren’t disclosed but Shire says it is considering its position

Preetika Rana and

Noemie Bisserbe

Updated April 24, 2018 11:25 a.m. ET

Takeda Pharmaceutical Co. on Tuesday made a fifth takeover proposal for rival drugmaker Shire PLC, a last-ditch move by the Japanese company that would likely value the rare-drug specialist at more than $60 billion.

In separate statements Tuesday, neither company disclosed the financial terms of the proposal. Shire said it was considering its position.

Takeda...